XERIS PHARMACEUTICALS INC's ticker is XERS and the CUSIP is 98422L107. A total of 106 filers reported holding XERIS PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.18 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $55,000 | -95.3% | 22,500 | -92.2% | 0.00% | – |
| Q2 2021 | $1,168,000 | -7.0% | 286,803 | +3.0% | 0.00% | – |
| Q1 2021 | $1,256,000 | +21.1% | 278,575 | +32.2% | 0.00% | – |
| Q4 2020 | $1,037,000 | +4.1% | 210,655 | +25.4% | 0.00% | – |
| Q3 2020 | $996,000 | +164.2% | 167,951 | +18.3% | 0.00% | – |
| Q2 2020 | $377,000 | +35.6% | 141,914 | -0.6% | 0.00% | – |
| Q1 2020 | $278,000 | -10.0% | 142,710 | +225.1% | 0.00% | – |
| Q4 2019 | $309,000 | -24.4% | 43,903 | +5.6% | 0.00% | – |
| Q3 2019 | $409,000 | +79.4% | 41,576 | +108.2% | 0.00% | – |
| Q2 2019 | $228,000 | +4.1% | 19,973 | -8.4% | 0.00% | – |
| Q1 2019 | $219,000 | +72.4% | 21,808 | +192.0% | 0.00% | – |
| Q4 2018 | $127,000 | +13.4% | 7,468 | +17.6% | 0.00% | – |
| Q3 2018 | $112,000 | – | 6,351 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|